InnoCentive Inc., the global leader in crowdsourced innovation and software platforms and ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, announced their partnership, that will provide InnoCentive@Work^TM pharmaceutical customers such as AstraZeneca and Eli Lilly, with a chemical editor tool suitable for generating standard chemical structures and molecular manipulations in an intuitive and simplified way.

“I am very excited about this partnership as crowdsourcing is becoming the next generation approach to problem solving”

InnoCentive has integrated ChemAxon’s, Marvin JS^TM, a state-of-the-art chemical editor that combines the chemical knowledge of MarvinSketch with the JavaScript-based browser technology to provide a quick and easy way to create chemical structures within InnoCentive@Work, a highly collaborative internal innovation management software platform, that allows companies to capture the collective thoughts and novel ideas from employees or a global community.

«Together with ChemAxon we have created the industry leading crowdsourcing solution for chemistry innovation. ChemAxon adds a critical innovators tool for new chemistry design for our Solvers to more easily compete for prizes in this field,» stated Craig Jones, Chairman and CEO of InnoCentive.

“I am very excited about this partnership as crowdsourcing is becoming the next generation approach to problem solving” – said Ferenc Csizmadia, CEO of ChemAxon. “We look forward to bringing more functionality as we extend our relationship with InnoCentive.”

ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, and InnoCentive, the global leader in crowdsourcing innovation solutions announce the integration of ChemAxon’s Marvin JS™, which enables convenient drawing of chemical structures and reactions/reaction mechanisms in InnoCentive’s innovation management software platform, InnoCentive@Work^TM.

ChemAxon has been involved in several collaborative, open innovation initiatives in the recent years. ChemAxon tools have been foundational part of Eli Lilly’s OIDD (Open Innovation Drug Discovery) initiative aiming to provide a platform for idea-sharing among the network of top global research institutions.  AstraZeneca enables research collaborations by providing a web-based open-innovation platform where chemical structures may be submitted.  Molecule characterization is provided by ChemAxon.  Similarly, ChemAxon provides core tools to support the European Lead Factory, a novel platform for innovative drug discovery, an IMI-supported public private partnership to enhance early drug discovery.

InnoCentive has integrated ChemAxon’s web-based drawing tool into their SaaS-based Challenge Driven Innovation^TM management software platform, InnoCentive@Work.  The tool allows users to draw chemical structures within InnoCentive@Work and save those structures to their database.  Marvin JS is a state-of-the-art chemical editor that combines the chemical knowledge of MarvinSketch with the JavaScript-based browser technology and provides a quick and easy way to insert chemical structures inline with the forum system InnoCentive has previously developed.

‘I am very excited about this partnership as crowdsourcing is becoming the next generation approach to problem solving’ – said Ferenc Csizmadia, CEO of ChemAxon. ‘We look forward to bringing more functionality as we extend our relationship with InnoCentive’

“Together with ChemAxon we have created the industry leading crowd sourcing solution for chemistry innovation. ChemAxon adds a critical innovators tool for new chemistry design for our Solvers to more easily compete for prizes in this field.” – stated Craig Jones, Chairman and CEO of InnoCentive.

Source:
https://www.chemaxon.com/news/innocentive-integrates-chemaxons-marvin-js/

---

 

InnoCentive

April 15, 2011